Barcelona

• Study to Evaluate the Efficacy and Safety of Deucrictibant for Prophylactic and On-demand Treatment of Angioedema Attacks in Adults with Acq … Recruiting
  2025-522051-26-00 5 2026-04-23 Acquired Angioedema due to C1 Inhibitor Deficiency
• Phase 1 trial of valemetostat and darolutamide in mCRPC Recruiting
  2025-522512-16-00 3 2026-04-23 Metastatic Castration Resistant Prostate Cancer (mCRPC)
• A study for adolescents who are depressed and thinking of suicide Recruiting
  2024-518615-19-00 5 2026-04-22 Major Depressive Disorder
• Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease Recruiting
  2025-521752-26-00 4 2026-04-22 Complement-Mediated Kidney Disease
• A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du … Recruiting
  2024-517943-29-00 5 2026-04-21 Pulmonary Hypertension associated with interstitial lung disease (WHO
• LIVER AKI: A trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with … Recruiting
  2025-521457-16-00 6 2026-04-21 descompensated hepatic cirrosis
• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting
  2025-522878-36-00 5 2026-04-20 Chronic Spontaneous Urticaria
• A Study of Transition Regimens to KPL-387 Monotherapy in Participants with Well-Controlled Recurrent Pericarditis Recruiting
  2025-523234-66-00 4 2026-04-17 Well-Controlled Recurrent Pericarditis
• A study to test the safety and disease progression following YTB323 (rapcabtagene autoleucel) administration in participant with progressive … Recruiting
  2024-514006-31-00 9 2026-04-16 Non-active Progressive Multiple Sclerosis (PMS)
• Testing HLX43 in Advanced Lung Cancer (Non-Small Cell): A Global Safety and Effectiveness Study Recruiting
  2025-523803-31-00 4 2026-04-16 Advanced non-small cell lung cancer (NSCLC)
• A clinical study of MK-1084 with other treatments for non-small cell lung cancer (MK-3475-01F) Recruiting
  2024-512248-47-00 9 2026-04-15 Non-small Cell Lung Cancer (NSCLC)
• A clinical study to test MEN2501 in patients with treatment-resistant ovarian cancer Recruiting
  2025-524168-39-00 1 2026-04-13 ​​Platinum-Resistant ovarian cancer​
• Dose-finding study of LAD603 in adults with alopecia areata Recruiting
  2025-523342-27-00 4 2026-04-10 Alopecia areata
• C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer. Recruiting
  2025-521756-39-00 1 2026-04-09 Non-muscle invasive bladder cancer (NMIBC)
• Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors Recruiting
  2025-523686-15-00 1 2026-04-08 Advanced or Metastatic Solid Tumors
• A Phase II Study Evaluating the Efficacy and Safety of Inavolisib plus Ribociclib plus Fulvestrant Versus Placebo plus Ribociclib plus Fulve … Recruiting
  2025-523013-28-00 4 2026-04-07 Endocrine-Resistant Hormone-Receptor-Positive, HER2-Negative Advanced
• A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation Recruiting
  2025-521521-33-00 10 2026-04-02 Kidney transplant rejection
• A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting
  2025-522191-86-00 5 2026-04-02 Focal segmental glomerulosclerosis
• Phase 3 Study of Revumenib in Combination with Intensive Chemotherapy in Newly Diagnosed NPM1-mutated AML Recruiting
  2025-522279-27-00 5 2026-04-02 Newly Diagnosed AML with an NPM1 mutation
• A clinical study of V940 in people with non-small cell lung cancer (V940-013) Recruiting
  2025-520902-37-00 4 2026-04-01 Non-small cell lung cancer stage IV
• Study to evaluate the effectiveness, safety, and quality of life of Bilaxten, an allergy medication, in children Recruiting
  2024-519550-36-00 6 2026-03-30 Allergic rhinoconjunctivitis
• VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA) Recruiting
  2024-512436-29-00 11 2026-03-27 CARDIOVASCULAR DISEASES
• Visugromab in Cachexia International Trial Recruiting
  2025-523533-25-00 10 2026-03-26 Cancer-associated Cachexia
• Pediatric Safety Follow-up Study of Prior Treatment with Romosozumab for Osteogenesis Imperfecta Recruiting
  2023-503293-21-00 5 2026-03-25 Osteogenesis Imperfecta

Showing 313–336 of 3,391 trials